[1. MAGRINI U, LUCIONI M, INCARDONA P, BOVERI E, PAULLI M. Castleman's disease: update. Pathologica, 2003; 95(5):227-9.]Search in Google Scholar
[2. KELLER AR, HOCHHOLZER L, CASTLEMAN B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29:670-683.10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#]Search in Google Scholar
[3. BATES DO, HARPER SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002; 39:225-237.10.1016/S1537-1891(03)00011-9]Search in Google Scholar
[4. PEH SC, SHAMINIE J, POPPEMA S, KIM LH. The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease. Singapore Med J. 2003; 44:185-191.]Search in Google Scholar
[5. MENKE DM. Ly-1b cells and Castleman Disease. Blood. 2000; 96:1614-1616.10.1182/blood.V96.4.1614]Search in Google Scholar
[6. CHEN WC, JONES D, HO CL et al. Cytogenetic anomalies in hyaline vascular Castleman disease: report of two cases with reappraisal of histogenesis. Cancer Genet Cytogenet 2006; 164:110-111.10.1016/j.cancergencyto.2005.06.009]Search in Google Scholar
[7. CRONIN DM, WARNKE RD. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009; 16:236-246.10.1097/PAP.0b013e3181a9d4d3]Search in Google Scholar
[8. LEE J, BAN JY, WON KY, et al. Expression of EGFR and folicullar dendritic markers in lymphoid follicles from patients with Castleman’s disease. Oncol Rep 2008; 20:851-856.]Search in Google Scholar
[9. NGUYEN DT, DIAMOND LW, HANSMANN ML, et al. Castleman’s disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology 1994; 24:437-443.10.1111/j.1365-2559.1994.tb00552.x]Search in Google Scholar
[10. HALL PA, DONAGHY M, COTTER FE, STANSFELD AG, LEVISON DA. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology 1989; 14:333-346.10.1111/j.1365-2559.1989.tb02162.x]Search in Google Scholar
[11. WEISENBURGER DD, NATHWANI BN, WINBERG CD, RAPPAPORT H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum. Pathol. 1985; 16:162-172.]Search in Google Scholar
[12. NICOLOSI AC, ALMASSI GH, KOMOROWSKI R. Cardiac tamponade secondary to giant lymph node hyperplasia (Castleman's disease). Chest 1994; 105(2):637-639.10.1378/chest.105.2.637]Search in Google Scholar
[13. SHAHIDI H, KVALE PA. Cardiac tamponade secondary to giant lymph node hyperplasia. Chest 1995; 107(2):581.10.1378/chest.107.2.581]Search in Google Scholar
[14. ZHANG C, MIAO Q, CHEN G, LIU X, MA G, CAO L, DENG H. Pericardial tamponade secondary to Castleman’s disease. Ann Thorac Surg. 2009; 88(6):2039.10.1016/j.athoracsur.2009.05.064]Search in Google Scholar
[15. SHIKAMA N, ISONO A, OTSUKA Y, TERANO T, HIRAI A. A case of POEMS syndrome with high concentrations of interleukin 6 in pericardial fluid. J Intern Med. 2001; 250(2):170.10.1046/j.1365-2796.2001.00863.x]Search in Google Scholar
[16. BOWNE WB, LEWIS JJ, FILIPPA DA, et al. The management of unicentric and multicentric Castleman disease; a report of 16 cases and a review of the literature. Cancer. 1999; 85:706-717.10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7]Search in Google Scholar